Soc Telemed Inc
NASDAQ:TLMD
Intrinsic Value
SOC Telemed, Inc. engages in the provision of acute care telemedicine services and technology to U.S. hospitals and healthcare. [ Read More ]
There is not enough data to reliably calculate the intrinsic value of TLMD.
Soc Telemed Inc's market capitalization is 296.6m USD.
TLMD stock price is 3 USD.
TLMD.
TLMD. Open DCF Valuation
TLMD. Open Relative Valuation
TLMD.
TLMD has positive Net Debt. This means that the company has more debt (74m USD) than cash and short-term investments (38m USD).
TLMD's ROIC (Return on Invested Capital) has decreased in the last 3 years from -22% to -30%, and is approaching profitability.
TLMD's ROE (Return on Equity) has decreased in the last 3 years from -33% to -41%, and is approaching profitability.
TLMD has positive Gross Profit for the last twelve months.
TLMD's Revenue is forecast to grow at a rate of 34% per year over the next 3 years.
TLMD has negative Operating Income for the last twelve months.
TLMD has negative Net Income for the last twelve months.
TLMD's ROE (Return on Equity) for the past 12 months is negative and is equal to -41%.
TLMD's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -30%.
TLMD's D/E (Debt to Equity) is very low and is equal to 0.42.
TLMD's long-term assets (274m USD) exceed its long-term liabilties (95m USD).
TLMD has negative Free Cash Flow for the last twelve months.
TLMD's short-term assets (58m USD) exceed its short-term liabilties (17m USD).
TLMD has negative three-year average ROE (Return on Equity): -33%. The company is not efficient at transforming stockholders' equity into net income.
TLMD has negative three-year average ROIC (Return on Invested Capital): -29%. The company is not efficient at using invested capital to generate operating income.
TLMD's Altman Z-Score is very low and is equal to -0.39.
TLMD doesn't generate enough operating income (-71m USD) to safely cover interest payments on its debt (10m USD).
Fundamental Analysis
Soc Telemed Inc
Balance Sheet Decomposition
Soc Telemed Inc
| Current Assets | 57.8m |
| Cash & Short-Term Investments | 37.7m |
| Receivables | 14.4m |
| Other Current Assets | 5.7m |
| Non-Current Assets | 215.8m |
| PP&E | 13.8m |
| Intangibles | 45.1m |
| Other Non-Current Assets | 156.9m |
| Current Liabilities | 17.4m |
| Accounts Payable | 5.4m |
| Accrued Liabilities | 11.2m |
| Other Current Liabilities | 824k |
| Non-Current Liabilities | 78m |
| Long-Term Debt | 73.9m |
| Other Non-Current Liabilities | 4.1m |
Earnings Waterfall
Soc Telemed Inc
|
Revenue
|
124.5m
USD
|
|
Cost of Revenue
|
-83.7m
USD
|
|
Gross Profit
|
40.7m
USD
|
|
Operating Expenses
|
-112.1m
USD
|
|
Operating Income
|
-71.4m
USD
|
|
Other Expenses
|
-15.2m
USD
|
|
Net Income
|
-86.6m
USD
|
Free Cash Flow Analysis
Soc Telemed Inc
What is Free Cash Flow?
TLMD Profitability Score
Profitability Due Diligence
Soc Telemed Inc's profitability score is 22/100. The higher the profitability score, the more profitable the company is.
Score
Soc Telemed Inc's profitability score is 22/100. The higher the profitability score, the more profitable the company is.
TLMD Solvency Score
Solvency Due Diligence
Soc Telemed Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
Soc Telemed Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TLMD Price Targets Summary
Soc Telemed Inc
Ownership
TLMD Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
TLMD Price
Soc Telemed Inc
| Average Annual Return | -24% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -95% |
| Market Capitalization | 296.6m USD |
| Shares Outstanding | 101 336 000 |
| Percentage of Shares Shorted | 2.93% |
Company Profile
Soc Telemed Inc
Country
Industry
Market Cap
Dividend Yield
Description
SOC Telemed, Inc. engages in the provision of acute care telemedicine services and technology to U.S. hospitals and healthcare. The company is headquartered in Herndon, Virginia and currently employs 226 full-time employees. The company went IPO on 2019-12-17. The firm provides technology enabled clinical solutions, which include acute teleNeurology, telePsychiatry, and teleICU. The firm offers technology platform, Telemed IQ that allows hospitals, health systems and other healthcare organizations the ability to provide telemedicine programs either with their its clinical team or in conjunction with its affiliated network of established, board-certified physicians and other provider specialists. Its cloud based Telemed IQ technology platform is an integrated and configurable technology solution that seamlessly combines voice, video, imaging, electronic medical record (EMR) integration, clinical workflow optimization, clinical resource management, analytics, predictive modeling and other reporting tools.
You don't have any saved screeners yet
